HealthcareServices

Chemiluminescence Immunoassay Market Future Outlook: Strong Growth Expected Toward $22.35 Billion by 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chemiluminescence immunoassay market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Chemiluminescence Immunoassay Market reach by 2030 starting from 2026 levels?

The chemiluminescence immunoassay market size has demonstrated robust growth recently. It is projected to expand from $14.85 billion in 2025 to $16.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.8%. The historic period’s growth can be attributed to factors such as the increasing prevalence of infectious and chronic diseases, the expansion of centralized diagnostic laboratories, a rising demand for accurate biomarker detection, broader adoption of automated laboratory systems, and the expanding use of immunoassays in clinical diagnostics.

The chemiluminescence immunoassay market is projected for significant expansion over the coming years, anticipated to reach $22.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. This projected growth stems from several factors, including a heightened need for early disease identification, greater embrace of personalized medicine diagnostics, the spread of decentralized testing approaches, increasing incorporation of AI-assisted diagnostic analysis, and larger investments in sophisticated clinical laboratory facilities. Key developments expected during this period involve the wider uptake of fully automated immunoassay analyzers, an escalating requirement for highly sensitive diagnostic kits, increased utilization of multiplex testing options, the expansion of rapid and point-of-care CLIA systems, and a stronger emphasis on consistent reagent performance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27252&type=smp

Which Drivers Are Influencing Long-Term Growth In The Chemiluminescence Immunoassay Market?

The increasing occurrence of infectious diseases is projected to drive the expansion of the chemiluminescence immunoassay market in the future. Infectious diseases are defined as conditions resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, which can transmit between individuals either directly or indirectly. The rise in antimicrobial resistance contributes to the increasing prevalence of these diseases, as it diminishes the effectiveness of standard treatments, thus enabling infections to endure and spread. Chemiluminescence immunoassays assist in diagnosing infectious diseases by offering highly sensitive and specific detection of biomarkers, which facilitates the early and precise identification of pathogens. These assays also shorten diagnostic wait times by yielding quick and dependable results, thereby enhancing patient care and treatment efficacy. For example, data from February 2024 released by the UK Health Security Agency, a government body in the UK, indicated that tuberculosis (a transmissible bacterial infection mainly impacting the lungs) instances in England climbed to 4,850 in 2023, representing a 10.7% increase from the 4,380 cases recorded in 2022. Consequently, the expanding occurrence of infectious diseases is propelling the expansion of the chemiluminescence immunoassay market.

How Is The Chemiluminescence Immunoassay Market Divided Into Segments?

The chemiluminescence immunoassay market covered in this report is segmented –

1) By Product Type: Analyzers, Kits, Reagents

2) By Sample Type: Blood, Saliva, Urine, Other Samples

3) By Technology: Chemiluminescence Enzyme Technology (CLEIA), Electrochemiluminescence Immunoassay (ECLI), Microparticle Chemiluminescence Immunoassay

4) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Other Applications

5) By End-User: Hospitals, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users

Subsegments:

1) By Analyzers: Fully Automated Analyzers, Semi Automated Analyzers, Portable Analyzers

2) By Kits: Detection Kits, Quantitative Kits, Qualitative Kits, Multiparameter Kits

3) By Reagents: Luminol Reagents, Isoluminol Reagents, Acridinium Ester Reagents, Other Reagents

What Upcoming Trends Are Likely To Define The Future Path Of The Chemiluminescence Immunoassay Market?

Major companies in the chemiluminescence immunoassay market are prioritizing the creation of advanced products, such as sophisticated chemiluminescence immunoassay analyzers, to enhance test accuracy, boost throughput, and deliver faster diagnostic results across various clinical applications. These analyzers are automated instruments that detect and quantify light emitted during chemical reactions to precisely identify specific biomarkers in diagnostic tests. For instance, in July 2023, Fapon Biotech Inc., a China-based biotechnology company, launched the Shine i8000/9000, a chemiluminescence immunoassay analyzer. This device is engineered for medium to large laboratories, offering quick preliminary results within 10 minutes and high precision, all within a compact, stable, and user-friendly design. Its prominent features include a 360-degree large-span display, one-touch bulk loading for reaction cups, a dual-tube backup substrate system, and automatic reaction cup disposal to minimize contamination. The analyzer’s fully automated workflow reduces manual intervention, while advanced algorithms improve result consistency, making it well-suited for high-volume diagnostic settings.

Which Key Market Players Are Investing In Expansion And Innovation Within The Chemiluminescence Immunoassay Market?

Major companies operating in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report

Which Regions Are Poised For Strategic Growth In The Chemiluminescence Immunoassay Market?

North America was the largest region in the chemiluminescence immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chemiluminescence Immunoassay Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27252&type=smp

Browse Through More Reports Similar to the Global Chemiluminescence Immunoassay Market 2026, By The Business Research Company

Services Procurement Market Report 2026

https://www.thebusinessresearchcompany.com/report/services-procurement-global-market-report

Commercial Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/commercial-services-global-market-report

Legal Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/legal-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795